Lakefront Biotherapeutics
No trades
Last report date
May 6, 2026
Report period
Q1 2026
EPS
0.21 EUR
Revenue
6.48 M EUR
7.42 EUR
320.88 M EUR
1.11 B EUR
44.55 M
About Lakefront Biotherapeutics
Sector
Industry
CEO
Henry O. Gosebruch
Website
Headquarters
Mechelen
Founded
1999
IPO date
Apr 14, 2005
Identifiers
2
ISIN BE0003818359
Lakefront Biotherapeutics is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of LKFT is 23.48 EUR — it has decreased by −1.25% in the past 24 hours. Watch Lakefront Biotherapeutics stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange Lakefront Biotherapeutics stocks are traded under the ticker LKFT.
LKFT stock has fallen by −2.94% compared to the previous week, the month change is a −1.49% fall, over the last year Lakefront Biotherapeutics has showed a −0.84% decrease.
We've gathered analysts' opinions on Lakefront Biotherapeutics future price: according to them, LKFT price has a max estimate of 37.00 EUR and a min estimate of 19.00 EUR. Watch LKFT chart and read a more detailed Lakefront Biotherapeutics stock forecast: see what analysts think of Lakefront Biotherapeutics and suggest that you do with its stocks.
LKFT reached its all-time high on Feb 20, 2020 with the price of 252.90 EUR, and its all-time low was 2.74 EUR and was reached on Oct 27, 2008. View more price dynamics on LKFT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LKFT stock is 1.45% volatile and has beta coefficient of 0.47. Track Lakefront Biotherapeutics stock price on the chart and check out the list of the most volatile stocks — is Lakefront Biotherapeutics there?
Today Lakefront Biotherapeutics has the market capitalization of 1.59 B, it has decreased by −2.56% over the last week.
Yes, you can track Lakefront Biotherapeutics financials in yearly and quarterly reports right on TradingView.
Lakefront Biotherapeutics is going to release the next earnings report on Aug 10, 2026. Keep track of upcoming events with our Earnings Calendar.
LKFT earnings for the last quarter are 0.21 EUR per share, whereas the estimation was −0.82 EUR resulting in a 125.77% surprise. The estimated earnings for the next quarter are −0.70 EUR per share. See more details about Lakefront Biotherapeutics earnings.
Lakefront Biotherapeutics revenue for the last quarter amounts to 6.48 M EUR, despite the estimated figure of 8.25 M EUR. In the next quarter, revenue is expected to reach 5.26 M EUR.
LKFT net income for the last quarter is 14.49 M EUR, while the quarter before that showed 782.15 M EUR of net income which accounts for 0.00% change. Track more Lakefront Biotherapeutics financial stats to get the full picture.
No, LKFT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 15, 2026, the company has 452 employees. See our rating of the largest employees — is Lakefront Biotherapeutics on this list?
Like other stocks, LKFT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Lakefront Biotherapeutics stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Lakefront Biotherapeutics technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Lakefront Biotherapeutics stock shows the sell signal. See more of Lakefront Biotherapeutics technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.